Schoenborn, Jamie (2012) Genetic Engineering of T-Cells to Benefit Anti-Tumor Immunotherapy. Science Spotlight, 2 (3).
Preview |
Text
Genetic Engineering of T-Cells to Benefit Anti-Tumor Immunotherapy.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (314kB) | Preview |
Article URL: http://www.bloodjournal.org/content/119/17/3940
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE, Rautitschek A, Forman SJ, Greenberg PD, Riddell SR, Press OW. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood. DOI: 10.1182/blood-2011-10-387969. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 10 Apr 2015 22:56 |
| Last Modified: | 10 Apr 2015 22:56 |
| URI: | http://authors.fhcrc.org/id/eprint/971 |
Repository Administrators Only
 |
View Item |
